Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 61% ± 22% | |
GABAergic neuron | 9 studies | 52% ± 19% | |
oligodendrocyte precursor cell | 7 studies | 28% ± 6% | |
interneuron | 6 studies | 49% ± 19% | |
neuron | 5 studies | 40% ± 17% | |
endothelial cell | 3 studies | 44% ± 22% | |
GABAergic interneuron | 3 studies | 58% ± 15% | |
granule cell | 3 studies | 53% ± 28% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 41% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 5101.98 | 2510 / 2642 | 77% | 4.96 | 542 / 705 |
peripheral blood | 75% | 1382.82 | 698 / 929 | 0% | 0 | 0 / 0 |
kidney | 49% | 588.46 | 44 / 89 | 14% | 0.34 | 126 / 901 |
spleen | 34% | 177.03 | 83 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 125.93 | 32 / 258 | 20% | 1.12 | 46 / 230 |
ovary | 1% | 2.46 | 1 / 180 | 26% | 1.00 | 110 / 430 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.75 | 7 / 29 |
heart | 10% | 73.29 | 90 / 861 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 10% | 0.43 | 29 / 286 |
uterus | 2% | 15.26 | 3 / 170 | 7% | 0.33 | 30 / 459 |
intestine | 3% | 12.66 | 30 / 966 | 4% | 0.25 | 21 / 527 |
lung | 2% | 8.33 | 11 / 578 | 5% | 0.21 | 56 / 1155 |
esophagus | 0% | 0.26 | 1 / 1445 | 5% | 0.29 | 10 / 183 |
thymus | 0% | 0.45 | 1 / 653 | 3% | 0.26 | 20 / 605 |
liver | 0% | 0 | 0 / 226 | 3% | 0.08 | 14 / 406 |
skin | 0% | 0.28 | 1 / 1809 | 3% | 0.09 | 16 / 472 |
bladder | 0% | 0 | 0 / 21 | 3% | 0.22 | 15 / 504 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.05 | 3 / 178 |
breast | 0% | 0 | 0 / 459 | 1% | 0.03 | 11 / 1118 |
adipose | 0% | 1.10 | 3 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.83 | 2 / 803 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
blood vessel | 0% | 0.27 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0045202 | Cellular component | synapse |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0022843 | Molecular function | voltage-gated monoatomic cation channel activity |
Gene name | CACNA1E |
Protein name | Voltage-gated calcium channel alpha 1E subunit Voltage-dependent calcium channel alpha 1E subunit Calcium voltage-gated channel subunit alpha1 E Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3) Voltage-dependent R-type calcium channel subunit alpha |
Synonyms | CACNL1A6 CACH6 |
Description | FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells . They are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. R-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by nickel. They are however insensitive to dihydropyridines (DHP). Calcium channels containing alpha-1E subunit could be involved in the modulation of firing patterns of neurons which is important for information processing. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. . |
Accessions | Q15878 ENST00000360108.7 Q9NYZ5 ENST00000621791.4 [Q15878-2] Q9NYZ6 ENST00000644521.1 ENST00000700188.1 ENST00000700190.1 Q9UN68 ENST00000524607.6 F8W9Z1 A0A2R8Y7W1 ENST00000367570.6 [Q15878-3] A0A8V8TPU6 ENST00000367573.7 [Q15878-1] A0A8V8TPE9 E9PIE8 Q9NY05 |